世界の心臓バイオマーカー検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cardiac Biomarkers Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5117
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、心臓バイオマーカー検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心筋クレアチンキナーゼ（CK-MB）、トロポニン（T＆I）、ミオグロビン、脳性ナトリウム利尿ペプチド（BNP）/NT-proBNP、虚血修飾アルブミン（IMA）、その他）、用途別市場規模（心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・心臓バイオマーカー検査の市場動向
・企業の競争状況、市場シェア
・心臓バイオマーカー検査の種類別市場規模と予測2016-2027（心筋クレアチンキナーゼ（CK-MB）、トロポニン（T＆I）、ミオグロビン、脳性ナトリウム利尿ペプチド（BNP）/NT-proBNP、虚血修飾アルブミン（IMA）、その他）
・心臓バイオマーカー検査の用途別市場規模と予測2016-2027（心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他）
・心臓バイオマーカー検査の北米市場規模2016-2027（アメリカ、カナダ）
・心臓バイオマーカー検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・心臓バイオマーカー検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・心臓バイオマーカー検査の中南米市場規模2016-2027（メキシコ、ブラジル）
・心臓バイオマーカー検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott Laboratories、Becton, Dickinson and Company、BioMerieux、Bio-Rad Laboratories, Inc.、Danaher Corporation、ROCHE、Siemens AG、Thermo Fisher Scientific, Inc.、PerkinElmer Inc.、Tosoh Corporation）
・結論

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.

Market Analysis and Insights: Global Cardiac Biomarkers Testing Market
The global Cardiac Biomarkers Testing market size is projected to reach US$ 11410 million by 2027, from US$ 7132.7 million in 2020, at a CAGR of 6.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cardiac Biomarkers Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cardiac Biomarkers Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cardiac Biomarkers Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cardiac Biomarkers Testing market.

Global Cardiac Biomarkers Testing Scope and Market Size
Cardiac Biomarkers Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Biomarkers Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others

Segment by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
ROCHE
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Myocardial Muscle Creatine Kinase (CK-MB)
1.2.3 Troponins (T and I)
1.2.4 Myoglobin
1.2.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
1.2.6 Ischemia-modified Albumin (IMA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cardiac Biomarkers Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cardiac Biomarkers Testing Market Perspective (2016-2027)
2.2 Cardiac Biomarkers Testing Growth Trends by Regions
2.2.1 Cardiac Biomarkers Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cardiac Biomarkers Testing Historic Market Share by Regions (2016-2021)
2.2.3 Cardiac Biomarkers Testing Forecasted Market Size by Regions (2022-2027)
2.3 Cardiac Biomarkers Testing Industry Dynamic
2.3.1 Cardiac Biomarkers Testing Market Trends
2.3.2 Cardiac Biomarkers Testing Market Drivers
2.3.3 Cardiac Biomarkers Testing Market Challenges
2.3.4 Cardiac Biomarkers Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cardiac Biomarkers Testing Players by Revenue
3.1.1 Global Top Cardiac Biomarkers Testing Players by Revenue (2016-2021)
3.1.2 Global Cardiac Biomarkers Testing Revenue Market Share by Players (2016-2021)
3.2 Global Cardiac Biomarkers Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cardiac Biomarkers Testing Revenue
3.4 Global Cardiac Biomarkers Testing Market Concentration Ratio
3.4.1 Global Cardiac Biomarkers Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Testing Revenue in 2020
3.5 Cardiac Biomarkers Testing Key Players Head office and Area Served
3.6 Key Players Cardiac Biomarkers Testing Product Solution and Service
3.7 Date of Enter into Cardiac Biomarkers Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cardiac Biomarkers Testing Breakdown Data by Type
4.1 Global Cardiac Biomarkers Testing Historic Market Size by Type (2016-2021)
4.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2022-2027)

5 Cardiac Biomarkers Testing Breakdown Data by Application
5.1 Global Cardiac Biomarkers Testing Historic Market Size by Application (2016-2021)
5.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cardiac Biomarkers Testing Market Size (2016-2027)
6.2 North America Cardiac Biomarkers Testing Market Size by Type
6.2.1 North America Cardiac Biomarkers Testing Market Size by Type (2016-2021)
6.2.2 North America Cardiac Biomarkers Testing Market Size by Type (2022-2027)
6.2.3 North America Cardiac Biomarkers Testing Market Size by Type (2016-2027)
6.3 North America Cardiac Biomarkers Testing Market Size by Application
6.3.1 North America Cardiac Biomarkers Testing Market Size by Application (2016-2021)
6.3.2 North America Cardiac Biomarkers Testing Market Size by Application (2022-2027)
6.3.3 North America Cardiac Biomarkers Testing Market Size by Application (2016-2027)
6.4 North America Cardiac Biomarkers Testing Market Size by Country
6.4.1 North America Cardiac Biomarkers Testing Market Size by Country (2016-2021)
6.4.2 North America Cardiac Biomarkers Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cardiac Biomarkers Testing Market Size (2016-2027)
7.2 Europe Cardiac Biomarkers Testing Market Size by Type
7.2.1 Europe Cardiac Biomarkers Testing Market Size by Type (2016-2021)
7.2.2 Europe Cardiac Biomarkers Testing Market Size by Type (2022-2027)
7.2.3 Europe Cardiac Biomarkers Testing Market Size by Type (2016-2027)
7.3 Europe Cardiac Biomarkers Testing Market Size by Application
7.3.1 Europe Cardiac Biomarkers Testing Market Size by Application (2016-2021)
7.3.2 Europe Cardiac Biomarkers Testing Market Size by Application (2022-2027)
7.3.3 Europe Cardiac Biomarkers Testing Market Size by Application (2016-2027)
7.4 Europe Cardiac Biomarkers Testing Market Size by Country
7.4.1 Europe Cardiac Biomarkers Testing Market Size by Country (2016-2021)
7.4.2 Europe Cardiac Biomarkers Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cardiac Biomarkers Testing Market Size (2016-2027)
8.2 Asia-Pacific Cardiac Biomarkers Testing Market Size by Type
8.2.1 Asia-Pacific Cardiac Biomarkers Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cardiac Biomarkers Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cardiac Biomarkers Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Cardiac Biomarkers Testing Market Size by Application
8.3.1 Asia-Pacific Cardiac Biomarkers Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cardiac Biomarkers Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cardiac Biomarkers Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region
8.4.1 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cardiac Biomarkers Testing Market Size (2016-2027)
9.2 Latin America Cardiac Biomarkers Testing Market Size by Type
9.2.1 Latin America Cardiac Biomarkers Testing Market Size by Type (2016-2021)
9.2.2 Latin America Cardiac Biomarkers Testing Market Size by Type (2022-2027)
9.2.3 Latin America Cardiac Biomarkers Testing Market Size by Type (2016-2027)
9.3 Latin America Cardiac Biomarkers Testing Market Size by Application
9.3.1 Latin America Cardiac Biomarkers Testing Market Size by Application (2016-2021)
9.3.2 Latin America Cardiac Biomarkers Testing Market Size by Application (2022-2027)
9.3.3 Latin America Cardiac Biomarkers Testing Market Size by Application (2016-2027)
9.4 Latin America Cardiac Biomarkers Testing Market Size by Country
9.4.1 Latin America Cardiac Biomarkers Testing Market Size by Country (2016-2021)
9.4.2 Latin America Cardiac Biomarkers Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cardiac Biomarkers Testing Market Size (2016-2027)
10.2 Middle East & Africa Cardiac Biomarkers Testing Market Size by Type
10.2.1 Middle East & Africa Cardiac Biomarkers Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cardiac Biomarkers Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cardiac Biomarkers Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Cardiac Biomarkers Testing Market Size by Application
10.3.1 Middle East & Africa Cardiac Biomarkers Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cardiac Biomarkers Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cardiac Biomarkers Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country
10.4.1 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Cardiac Biomarkers Testing Introduction
11.1.4 Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Introduction
11.2.4 Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Cardiac Biomarkers Testing Introduction
11.3.4 BioMerieux Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.3.5 BioMerieux Recent Development
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Details
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.4.5 Bio-Rad Laboratories, Inc. Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Cardiac Biomarkers Testing Introduction
11.5.4 Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.5.5 Danaher Corporation Recent Development
11.6 ROCHE
11.6.1 ROCHE Company Details
11.6.2 ROCHE Business Overview
11.6.3 ROCHE Cardiac Biomarkers Testing Introduction
11.6.4 ROCHE Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.6.5 ROCHE Recent Development
11.7 Siemens AG
11.7.1 Siemens AG Company Details
11.7.2 Siemens AG Business Overview
11.7.3 Siemens AG Cardiac Biomarkers Testing Introduction
11.7.4 Siemens AG Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.7.5 Siemens AG Recent Development
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Details
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.8.5 Thermo Fisher Scientific, Inc. Recent Development
11.9 PerkinElmer Inc.
11.9.1 PerkinElmer Inc. Company Details
11.9.2 PerkinElmer Inc. Business Overview
11.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Introduction
11.9.4 PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.9.5 PerkinElmer Inc. Recent Development
11.10 Tosoh Corporation
11.10.1 Tosoh Corporation Company Details
11.10.2 Tosoh Corporation Business Overview
11.10.3 Tosoh Corporation Cardiac Biomarkers Testing Introduction
11.10.4 Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2016-2021)
11.10.5 Tosoh Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Myocardial Muscle Creatine Kinase (CK-MB)
Table 3. Key Players of Troponins (T and I)
Table 4. Key Players of Myoglobin
Table 5. Key Players of Brain Natriuretic Peptide (BNPs) or NT-proBNP
Table 6. Key Players of Ischemia-modified Albumin (IMA)
Table 7. Key Players of Others
Table 8. Global Cardiac Biomarkers Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cardiac Biomarkers Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Cardiac Biomarkers Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Cardiac Biomarkers Testing Market Share by Regions (2016-2021)
Table 12. Global Cardiac Biomarkers Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Cardiac Biomarkers Testing Market Share by Regions (2022-2027)
Table 14. Cardiac Biomarkers Testing Market Trends
Table 15. Cardiac Biomarkers Testing Market Drivers
Table 16. Cardiac Biomarkers Testing Market Challenges
Table 17. Cardiac Biomarkers Testing Market Restraints
Table 18. Global Cardiac Biomarkers Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Cardiac Biomarkers Testing Market Share by Players (2016-2021)
Table 20. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarkers Testing as of 2020)
Table 21. Ranking of Global Top Cardiac Biomarkers Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Cardiac Biomarkers Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cardiac Biomarkers Testing Product Solution and Service
Table 25. Date of Enter into Cardiac Biomarkers Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cardiac Biomarkers Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Cardiac Biomarkers Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Cardiac Biomarkers Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Cardiac Biomarkers Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Cardiac Biomarkers Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Cardiac Biomarkers Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Cardiac Biomarkers Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Cardiac Biomarkers Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Cardiac Biomarkers Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Cardiac Biomarkers Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Cardiac Biomarkers Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Cardiac Biomarkers Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Cardiac Biomarkers Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Cardiac Biomarkers Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Cardiac Biomarkers Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Cardiac Biomarkers Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cardiac Biomarkers Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cardiac Biomarkers Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cardiac Biomarkers Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Cardiac Biomarkers Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Cardiac Biomarkers Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Cardiac Biomarkers Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Cardiac Biomarkers Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Cardiac Biomarkers Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Cardiac Biomarkers Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Cardiac Biomarkers Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cardiac Biomarkers Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cardiac Biomarkers Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cardiac Biomarkers Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Cardiac Biomarkers Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbott Laboratories Company Details
Table 66. Abbott Laboratories Business Overview
Table 67. Abbott Laboratories Cardiac Biomarkers Testing Product
Table 68. Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 69. Abbott Laboratories Recent Development
Table 70. Becton, Dickinson and Company Company Details
Table 71. Becton, Dickinson and Company Business Overview
Table 72. Becton, Dickinson and Company Cardiac Biomarkers Testing Product
Table 73. Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 74. Becton, Dickinson and Company Recent Development
Table 75. BioMerieux Company Details
Table 76. BioMerieux Business Overview
Table 77. BioMerieux Cardiac Biomarkers Testing Product
Table 78. BioMerieux Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 79. BioMerieux Recent Development
Table 80. Bio-Rad Laboratories, Inc. Company Details
Table 81. Bio-Rad Laboratories, Inc. Business Overview
Table 82. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Product
Table 83. Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 84. Bio-Rad Laboratories, Inc. Recent Development
Table 85. Danaher Corporation Company Details
Table 86. Danaher Corporation Business Overview
Table 87. Danaher Corporation Cardiac Biomarkers Testing Product
Table 88. Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 89. Danaher Corporation Recent Development
Table 90. ROCHE Company Details
Table 91. ROCHE Business Overview
Table 92. ROCHE Cardiac Biomarkers Testing Product
Table 93. ROCHE Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 94. ROCHE Recent Development
Table 95. Siemens AG Company Details
Table 96. Siemens AG Business Overview
Table 97. Siemens AG Cardiac Biomarkers Testing Product
Table 98. Siemens AG Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 99. Siemens AG Recent Development
Table 100. Thermo Fisher Scientific, Inc. Company Details
Table 101. Thermo Fisher Scientific, Inc. Business Overview
Table 102. Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 103. Thermo Fisher Scientific, Inc. Recent Development
Table 104. PerkinElmer Inc. Company Details
Table 105. PerkinElmer Inc. Business Overview
Table 106. PerkinElmer Inc. Cardiac Biomarkers Testing Product
Table 107. PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 108. PerkinElmer Inc. Recent Development
Table 109. Tosoh Corporation Company Details
Table 110. Tosoh Corporation Business Overview
Table 111. Tosoh Corporation Cardiac Biomarkers Testing Product
Table 112. Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2016-2021) & (US$ Million)
Table 113. Tosoh Corporation Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiac Biomarkers Testing Market Share by Type: 2020 VS 2027
Figure 2. Myocardial Muscle Creatine Kinase (CK-MB) Features
Figure 3. Troponins (T and I) Features
Figure 4. Myoglobin Features
Figure 5. Brain Natriuretic Peptide (BNPs) or NT-proBNP Features
Figure 6. Ischemia-modified Albumin (IMA) Features
Figure 7. Others Features
Figure 8. Global Cardiac Biomarkers Testing Market Share by Application: 2020 VS 2027
Figure 9. Myocardial Infarction Case Studies
Figure 10. Congestive Heart Failure Case Studies
Figure 11. Acute Coronary Syndrome Case Studies
Figure 12. Atherosclerosis Case Studies
Figure 13. Others Case Studies
Figure 14. Cardiac Biomarkers Testing Report Years Considered
Figure 15. Global Cardiac Biomarkers Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Cardiac Biomarkers Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Cardiac Biomarkers Testing Market Share by Regions: 2020 VS 2027
Figure 18. Global Cardiac Biomarkers Testing Market Share by Regions (2022-2027)
Figure 19. Global Cardiac Biomarkers Testing Market Share by Players in 2020
Figure 20. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarkers Testing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Cardiac Biomarkers Testing Revenue in 2020
Figure 22. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2016-2021)
Figure 23. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2022-2027)
Figure 24. North America Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Cardiac Biomarkers Testing Market Share by Type (2016-2027)
Figure 26. North America Cardiac Biomarkers Testing Market Share by Application (2016-2027)
Figure 27. North America Cardiac Biomarkers Testing Market Share by Country (2016-2027)
Figure 28. United States Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cardiac Biomarkers Testing Market Share by Type (2016-2027)
Figure 32. Europe Cardiac Biomarkers Testing Market Share by Application (2016-2027)
Figure 33. Europe Cardiac Biomarkers Testing Market Share by Country (2016-2027)
Figure 34. Germany Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cardiac Biomarkers Testing Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Cardiac Biomarkers Testing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Cardiac Biomarkers Testing Market Share by Region (2016-2027)
Figure 44. China Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cardiac Biomarkers Testing Market Share by Type (2016-2027)
Figure 52. Latin America Cardiac Biomarkers Testing Market Share by Application (2016-2027)
Figure 53. Latin America Cardiac Biomarkers Testing Market Share by Country (2016-2027)
Figure 54. Mexico Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cardiac Biomarkers Testing Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Cardiac Biomarkers Testing Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Cardiac Biomarkers Testing Market Share by Country (2016-2027)
Figure 60. Turkey Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Cardiac Biomarkers Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Laboratories Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 64. Becton, Dickinson and Company Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 65. BioMerieux Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 66. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 67. Danaher Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 68. ROCHE Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 69. Siemens AG Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 70. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 71. PerkinElmer Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 72. Tosoh Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界の心臓POC検査装置＆キット市場規模・現状・予測（2021年-2027年）

Global Cardiac POC Testing Devices and Kits Market Size, Status and Forecast 2021-2027
QFJ1-5118 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、心臓POC検査装置＆キットの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心臓POCテストアナライザー、心臓POCテストキット）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界のLFAベース心臓マーカー市場規模・現状・予測（2021年-2027年）

Global LFA-based Cardiac Marker Market Size, Status and Forecast 2021-2027
QFJ1-4424 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、LFAベース心臓マーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（トロポニン、CK-MB、ミオグロビン、その他）、用途別市場規模（臨床検査、ポイントオブケア検査）、主要地域別市場規模（北米、アメ...

世界の心臓リーダーシステム市場規模・現状・予測（2021年-2027年）

Global Cardiac Reader System Market Size, Status and Forecast 2021-2027
QFJ1-5647 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、心臓リーダーシステムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（トロポニン、クレアチンキナーゼ、その他）、用途別市場規模（病院＆診療所、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の獣医におけるヘモグロビンA1C検査市場規模・現状・予測（2021年-2027年）

Global Hemoglobin A1C Testing in Veterinary Market Size, Status and Forecast 2021-2027
QFJ1-5190 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、獣医におけるヘモグロビンA1C検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（テストキット、アナライザー）、用途別市場規模（犬、猫）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の細菌学検査市場規模・現状・予測（2021年-2027年）

Global Bacteriological Testing Market Size, Status and Forecast 2021-2027
QFJ1-3888 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、細菌学検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型、迅速型）、用途別市場規模（食品＆飲料産業、水、医薬品、化粧品、感染症診断）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027
QFJ1-4605 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界の食物アレルギー検査装置市場規模・現状・予測（2021年-2027年）

Global Food Allergy Testing Device Market Size, Status and Forecast 2021-2027
QFJ1-5169 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、食物アレルギー検査装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液検査キット、食品検査装置）、用途別市場規模（離乳食用、ベーカリー・菓子製品用、乳製品用、魚介類用、その他）、主要地域別市場規模...

世界のタバコ代謝遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Cigarette Metabolism Gene Testing Market Size, Status and Forecast 2021-2027
QFJ1-4020 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、タバコ代謝遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝学的検査、遺伝子発現検査、診断用検査、生殖発生学的検査）、用途別市場規模（病院、診療所、診断センター）、主要地域別市場規模（北米...

世界のウエストナイルウイルス検査市場規模・現状・予測（2021年-2027年）

Global West Nile Virus Testing Market Size, Status and Forecast 2021-2027
QFJ1-5038 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ウエストナイルウイルス検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、免疫組織検査、その他）、用途別市場規模（病院、血液銀行、外科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の非侵襲的出生前検査キット市場規模・現状・予測（2021年-2027年）

Global Non-Invasive Prenatal Testing Kit Market Size, Status and Forecast 2021-2027
QFJ1-5892 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、非侵襲的出生前検査キットの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（高リスク＆平均リスク、低リスク）、用途別市場規模（0〜12週間、13〜24週間、25〜36週間）、主要地域別市場規模（北米、アメ...

世界の脳性ナトリウム利尿ペプチド（BNP）検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Brain Natriuretic Peptide (BNP) Test Market The global Brain Natriuretic Peptide (BNP) Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
世界のクレアチンキナーゼテスト市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Creatine Kinase Test Market The global Creatine Kinase Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
世界の心臓POC検査装置＆キット市場規模・現状・予測（2021年-2027年） Evolution of cardiac point of care testing resulting from the application of innovative technology in medical science for improved disease diagnosis which further leads to betterment of cardiac health. Market Analysis and Insights: Global Cardiac POC Testing Devices and Kits Market The global Cardia…
世界の心臓リーダーシステム市場規模・現状・予測（2021年-2027年） Cardiac Reader System provide high throughput point-of-care solutions for the diagnosis of myocardial infarction and other cardiac-related diseases by measuring levels of STAT, cardiac troponin, CKM and CKB, myoglobin and/or D-dimer in approximately as low as 14 minutes; equivalent to 36 tests per h…
世界のLFAベース心臓マーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global LFA-based Cardiac Marker Market The global LFA-based Cardiac Marker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …